Emergent Biosolutions

Policymakers are enthusiastic about supporting domestic manufacturing of drugs and medical devices. Health care companies want to make sure they get their share of that support.

A problematic Emergent vaccine plant in Maryland still lacks approval, even after FDA declared some doses produced there are safe to use.